{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:46:34Z","timestamp":1761597994678,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.05.037","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T13:45:44Z","timestamp":1538142344000},"page":"369-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)"],"prefix":"10.1016","volume":"277","author":[{"given":"Olivier S.","family":"Descamps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Van Caenegem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel P.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Balligand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Bondue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Castermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Chenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"de Leener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"De Meester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Demeure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"De Raedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Elegeert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Kacenelenbogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Paquot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Vanakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Vanoverschelde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-7776","authenticated-orcid":false,"given":"Ann","family":"Verhaegen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Wallemacq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Rietzschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.atherosclerosis.2018.05.037_bib1","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-0004.1997.tb02478.x","article-title":"High prevalence of a novel mutation in exon 4 in the LDL receptor gene in Belgium","volume":"51","author":"Descamps","year":"1997","journal-title":"Clin. Genet."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.05.037_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2362.2001.00915.x","article-title":"Impact of genetic defects on atheroclerosis in patients suspected of familial hypercholesterolemia","volume":"31","author":"Descamps","year":"2001","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2362.2003.01094.x","article-title":"Impact of Genetic Defects on coronary atherosclerosis in patients suspected of familial hypercholesterolemia","volume":"33","author":"Descamps","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"issue":"Supp 4","key":"10.1016\/j.atherosclerosis.2018.05.037_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1567-5688(03)00024-2","article-title":"Clinical and preclinical myocardial ischaemia in familial hypercholesterolemia","author":"Descamps","year":"2003","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.05.037_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mcpr.2001.0378","article-title":"Low-density lipoprotein receptor gene mutation analysis and clinical correlation in Belgian hypercholesterolaemics","volume":"15","author":"Van Gaal","year":"2001","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2016.02.009","article-title":"Homozygous familial hypercholesterolemia in childhood: genotype-phenotype description, established therapies and perspectives","volume":"247","author":"Sanna","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.05.037_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.05.037_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","article-title":"EUROASPIRE Investigators. Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology","volume":"241","author":"De Backer","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.05.037_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.18553\/jmcp.2013.19.2.139","article-title":"Management of familial hypercholesterolemia: a review of the recommendations from the national lipid association expert panel on familial hypercholesterolemia","volume":"19","author":"Robinson","year":"2013","journal-title":"J.\u00a0Manag. Care Pharm."},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2018.05.037_bib13","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib14","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/bmj.294.6587.1588","article-title":"Changes in serum lipid concentrations during first 24 hours after myocardial infarction","volume":"294","author":"Jackson","year":"1987","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.05.037_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1378\/chest.120.4.1196","article-title":"Effect of acute myocardial infarction on cholesterol ratios","volume":"120","author":"Wattanasuwan","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.05.037_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.05.037_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0021-9150(01)00533-0","article-title":"The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia","volume":"157","author":"Descamps","year":"2001","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.05.037_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5551\/jat.14159","article-title":"Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J.\u00a0Atherosclerosis Thromb."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.05.037_bib19","first-page":"22","article-title":"Clinical utility gene card for: hyperlipoproteinemia, TYPE II","volume":"2014","author":"Kassner","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"43","key":"10.1016\/j.atherosclerosis.2018.05.037_bib20","first-page":"2996","article-title":"ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia","volume":"36","author":"Kastelein","year":"2015","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.05.037_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10557-016-6685-y","article-title":"Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia and LDL-C of 160 mg\/dl or higher","volume":"30","author":"Ginsberg","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"9965","key":"10.1016\/j.atherosclerosis.2018.05.037_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","article-title":"RUTHERFORD-2 Investigators. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.05.037_bib23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/bcp.13066","article-title":"Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia","volume":"82","author":"Gouni-Berthold","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.05.037_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.05.037_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am. J. Cardiol."},{"issue":"36","key":"10.1016\/j.atherosclerosis.2018.05.037_bib26","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"For the European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.05.037_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/HJR.0b013e328012c380","article-title":"Asklepios Investigators. Rationale, design, methods and baseline characteristics of the Asklepios Study","volume":"14","author":"Rietzschel","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2018.05.037_bib28","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018302806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018302806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:34:39Z","timestamp":1720647279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018302806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":28,"alternative-id":["S0021915018302806"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.037","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}